MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
MAX dimerization protein 3 (MXD3), a transcriptional regulator of the MXD3 superfamily, is a part of the MYC–MAX–MXD network. However, its role in tumors has been reported in several cancers, such as B-cell acute lymphoblastic leukemia, medulloblastoma, neuroblastoma, and glioblastoma. Based on TCGA...
Saved in:
Main Authors: | Xiaoyu Zhang, Xiaoqin He, Yue Li, Yangtao Xu, Wenliang Chen, Xin Liu, Xinyao Hu, Lin Xiong, Ximing Xu |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/03a918ac26324d8abc5c93749ca89d8d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
by: Xin Jin, et al.
Published: (2021) -
Prognostic role of oxytocin receptor in colon adenocarcinoma
by: Sun Junjie, et al.
Published: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
by: Guojun Lu, et al.
Published: (2021) -
Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
by: Lichun Lu, et al.
Published: (2021) -
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021)